Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-22-015662

Options or other derivatives

  • Director acquired 38,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Climaco John M Director 2022-06-20 Grant or award · Stock option (right to buy) +23,333 47,501 D: show line 1 in the form
Climaco John M Director 2022-06-20 Grant or award · Stock option (right to buy) +15,000 62,501 D: show line 2 in the form
Loading xslF345X03/rdgdoc.xml…